Tolerance and Benefits of Mandibular Advanced Device for Snoring and Sleep Apnea in Oropharyngeal Cancer.

ConditionsOral Cancer Pharynx Cancer Sleep Apnea Snoring Oral Squamous Cell Carcinoma

Trial statusRecruiting

Trial phaseNot applicable

Trial typeInterventional

Biological sexAll

Age18-65

SponsorCentre hospitalier de l'Université de Montréal (CHUM)

About this trial

Evaluation of the Tolerance and Benefits of Mandibular Advanced Device (MAD) for Snoring and Sleep Apnea in Patients with Oropharyngeal Cancer (OPC): Mixed Design Study.

Eligibility criteria

Qualifiers

oropharyngeal cancer diagnosis

18 years of age and over

female or male; ratio of 1/4 toward men

had received RTH in the Department of Radiation Oncology,

Disqualifiers

pregnant or breastfeeding woman;

edentation preventing retention of the oral appliance;

taking opioid or anxiolitic type medications;

history of major depression,

Trial design

Treatments tested in this trial

Ronco-Onco and MAD

Treatment groups

35 Participants

are divided into 2 treatment groups

Sponsors and collaborators

Centre hospitalier de l'Université de Montréal (CHUM)

Lead sponsor

Source ClinicalTrials.gov